These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2566914)

  • 1. Imaging techniques in Parkinson's disease.
    Martin WR
    Mov Disord; 1989; 4 Suppl 1():S63-9. PubMed ID: 2566914
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.
    Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O
    Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug development for neurodegenerative diseases: role of PET.
    Rinne JO
    Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive neuropsychology of Parkinson's disease: a functional neuroimaging perspective.
    Owen AM; Doyon J
    Adv Neurol; 1999; 80():49-56. PubMed ID: 10410702
    [No Abstract]   [Full Text] [Related]  

  • 6. Thirty years of dopamine research.
    Carlsson A
    Adv Neurol; 1993; 60():1-10. PubMed ID: 8093570
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral blood flow and oxygen metabolism measurement with positron emission tomography in Parkinson's disease.
    Leenders KL; Wolfson L; Jones T
    Monogr Neural Sci; 1984; 11():180-6. PubMed ID: 6610825
    [No Abstract]   [Full Text] [Related]  

  • 8. Is it Parkinson's disease?
    Hely M
    Aust Fam Physician; 1992 Oct; 21(10):1411-6. PubMed ID: 1444967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain glucose metabolism in Parkinson's disease.
    Metter EJ; Kuhl DE; Riege WH
    Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
    [No Abstract]   [Full Text] [Related]  

  • 10. PET: its clinical role in neurology.
    Brooks D
    J Neurol Neurosurg Psychiatry; 1991 Jan; 54(1):1-5. PubMed ID: 1672706
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography in movement disorders.
    Martin WR
    Can J Neurol Sci; 1985 Feb; 12(1):6-10. PubMed ID: 3156662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imaging brain function with autoradiography and positron emission tomography].
    Kato M; Hosokawa S; Kuwabara Y
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1182-91. PubMed ID: 1972583
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
    Antonini A; Kazumata K; Feigin A; Mandel F; Dhawan V; Margouleff C; Eidelberg D
    Mov Disord; 1998 Mar; 13(2):268-74. PubMed ID: 9539340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: metabolic and pharmacological approaches with positron emission tomography.
    Raichle ME; Perlmutter JS; Fox PT
    Ann Neurol; 1984; 15 Suppl():S131-2. PubMed ID: 6611113
    [No Abstract]   [Full Text] [Related]  

  • 15. Parkinson's disease: positron emission tomographic studies.
    Martin WR
    Semin Neurol; 1989 Dec; 9(4):345-50. PubMed ID: 2701779
    [No Abstract]   [Full Text] [Related]  

  • 16. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
    Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
    Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
    [No Abstract]   [Full Text] [Related]  

  • 17. PET and movement disorders.
    Brooks DJ; Frackowiak RS
    J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):68-77. PubMed ID: 2666580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate and Parkinson's disease.
    Greenberg DA
    Ann Neurol; 1994 Jun; 35(6):639. PubMed ID: 7911652
    [No Abstract]   [Full Text] [Related]  

  • 19. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
    Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
    Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical signalling in the globus pallidus in parkinsonism.
    Brotchie J; Crossman A; Mitchell I; Duty S; Carroll C; Cooper A; Henry B; Hughes N; Maneuf Y
    Prog Brain Res; 1993; 99():125-39. PubMed ID: 7906423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.